利妥昔单抗治疗后，一名B细胞慢性淋巴细胞白血病且表面抗原阴性患者发生暴发性乙型肝炎。 - Suppr

Suppr

超能文献

Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy.

作者信息

Niscola P, Del Principe M I, Maurillo L, Venditti A, Buccisano F, Piccioni D, Amadori S, Del Poeta G

出版信息

Leukemia. 2005 Oct;19(10):1840-1. doi: 10.1038/sj.leu.2403914.

DOI:10.1038/sj.leu.2403914

PMID:16094417

Abstract

摘要

相似文献

Fulminant B hepatitis in a surface antigen-negative patient with B-cell chronic lymphocytic leukaemia after rituximab therapy.

Leukemia. 2005 Oct;19(10):1840-1. doi: 10.1038/sj.leu.2403914.

HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb.

J Infect Chemother. 2005 Aug;11(4):189-91. doi: 10.1007/s10156-005-0385-z.

Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.

Ann Hematol. 2011 Oct;90(10):1219-23. doi: 10.1007/s00277-011-1241-0. Epub 2011 Apr 26.

Hepatitis B re-activation with rituximab therapy: treat the patient not the disease.

Liver Int. 2011 Mar;31(3):277-9. doi: 10.1111/j.1478-3231.2011.02452.x. Epub 2011 Jan 25.

Reactivation of hepatitis B virus following rituximab-based regimens: a serious complication in both HBsAg-positive and HBsAg-negative patients.

Ann Hematol. 2010 Mar;89(3):255-62. doi: 10.1007/s00277-009-0806-7. Epub 2009 Aug 21.

Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy.

Hepatology. 2006 Feb;43(2):209-20. doi: 10.1002/hep.21051.

Rituximab in chronic lymphocytic leukemia.

Semin Hematol. 2010 Apr;47(2):156-69. doi: 10.1053/j.seminhematol.2010.01.005.

Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.

J Clin Oncol. 2009 Feb 1;27(4):605-11. doi: 10.1200/JCO.2008.18.0182. Epub 2008 Dec 15.

Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with acute promyelocytic leukemia treated with arsenic trioxide.

Ann Hematol. 2014 Feb;93(2):351-2. doi: 10.1007/s00277-013-1804-3. Epub 2013 Jun 1.

Severe liver dysfunction from hepatitis C virus reactivation following alemtuzumab treatment for chronic lymphocytic leukaemia.

Br J Haematol. 2010 Feb;148(3):484-6. doi: 10.1111/j.1365-2141.2009.07972.x. Epub 2009 Oct 28.

引用本文的文献

Single-cell transcriptomic profiling reveals dysregulation of B-cell subset function in patients with chronic hepatitis B.

Hepatol Int. 2025 Jun 9. doi: 10.1007/s12072-025-10846-y.

Clinical outcomes of patients with acute lymphoblastic leukemia receiving the hyper-CVAD regimen and assessment of the risk of hepatitis flares due to hepatitis B virus reactivation after chemotherapy.

Arch Med Sci. 2021 Mar 19;18(1):121-128. doi: 10.5114/aoms/103606. eCollection 2022.

Safety and efficacy of CAR-T cell targeting BCMA in patients with multiple myeloma coinfected with chronic hepatitis B virus.

J Immunother Cancer. 2020 Aug;8(2). doi: 10.1136/jitc-2020-000927.

Perforin inhibition protects from lethal endothelial damage during fulminant viral hepatitis.

Nat Commun. 2018 Nov 15;9(1):4805. doi: 10.1038/s41467-018-07213-x.

Detection of the Incidence of HBV, HCV Infection and Febrile Neutropenia Associated With CHOP With or Without Rituximab in Diffuse Large B-Cell Lymphoma-Treated Patients.

Hosp Pharm. 2018 Jun;53(3):194-197. doi: 10.1177/0018578717741394. Epub 2017 Nov 16.

Review of targeted therapy in chronic lymphocytic leukemia: what a radiologist needs to know about CT interpretation.

Cancer Imaging. 2018 Apr 18;18(1):13. doi: 10.1186/s40644-018-0146-8.

Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients.

Cell Mol Immunol. 2015 May;12(3):309-16. doi: 10.1038/cmi.2015.25. Epub 2015 Apr 6.

Efficacy of prophylactic lamivudine to prevent hepatitis B virus reactivation in B-cell lymphoma treated with rituximab-containing chemotherapy.

Support Care Cancer. 2013 May;21(5):1265-71. doi: 10.1007/s00520-012-1656-8. Epub 2012 Nov 15.

Patients with hematological malignancies and serological signs of prior resolved hepatitis B.

World J Gastrointest Oncol. 2012 Mar 15;4(3):37-45. doi: 10.4251/wjgo.v4.i3.37.

Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL).

J Blood Med. 2010;1:115-22. doi: 10.2147/JBM.S7138. Epub 2010 Jun 21.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验